G Frieri

Summary

Country: Italy

Publications

  1. ncbi request reprint Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis
    G Frieri
    Gastroenterology, University of L Aquila, L Aquila, Italy
    Dig Liver Dis 37:92-6. 2005
  2. pmc Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis
    G Frieri
    Cattedra di Gastroenterologia, Universita di L Aquila, L Aquila, Italy
    Gut 47:410-4. 2000
  3. ncbi request reprint Management of colonic diverticular disease
    Giuseppe Frieri
    Gastroenterology Unit, School of Medicine and Dentistry, University of L Aquila, L Aquila, Italy
    Digestion 73:58-66. 2006
  4. doi request reprint Early acid perception in NERD
    G Frieri
    Gastroenterology Unit, Internal Medicine Department, University of L Aquila, L Aquila, Italy
    Dis Esophagus 24:127-30. 2011
  5. ncbi request reprint Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment
    G Frieri
    Gastroenterology Unit, University of L Aquila, Italy
    Aliment Pharmacol Ther 13:1413-7. 1999
  6. ncbi request reprint Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI
    V A Pupillo
    Dipartimento di Diagnostica per Immagini, Universita degli Studi di L Aquila, Via della Mainetta 88D, Coppito, L Aquila, Italy
    Radiol Med 112:798-809. 2007
  7. ncbi request reprint Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation
    R Sferra
    Department of Experimental Medicine, University of L Aquila, L Aquila, Italy
    Eur Rev Med Pharmacol Sci 16:1484-98. 2012
  8. ncbi request reprint Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon
    Giovanni Latella
    Cattedra di Gastroenterologia, Universita di L Aquila, Via S Sisto 22E, 67100 L Aquila, Italy
    Int J Colorectal Dis 18:55-62. 2003
  9. ncbi request reprint GI distension in severe ulcerative colitis
    Giovanni Latella
    Gastroenterology Unit I, University La Sapienza, Rome, Italy
    Am J Gastroenterol 97:1169-75. 2002

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis
    G Frieri
    Gastroenterology, University of L Aquila, L Aquila, Italy
    Dig Liver Dis 37:92-6. 2005
    ..In cross-sectional studies, it was demonstrated that the therapeutic effect of mesalazine is closely related to its mucosal concentration...
  2. pmc Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis
    G Frieri
    Cattedra di Gastroenterologia, Universita di L Aquila, L Aquila, Italy
    Gut 47:410-4. 2000
    ..The treatment of ulcerative colitis (UC) with 5-aminosalicylic acid (5-ASA) does not have the same therapeutic effect in all patients. We tested the hypothesis that the effectiveness of the drug is related to its mucosal concentration...
  3. ncbi request reprint Management of colonic diverticular disease
    Giuseppe Frieri
    Gastroenterology Unit, School of Medicine and Dentistry, University of L Aquila, L Aquila, Italy
    Digestion 73:58-66. 2006
    ..It is indicated in diffuse peritonitis, abscesses, fistulas, stenosis and after the second to fourth attack of uncomplicated diverticulitis. Young people and immunocompromised patients are more likely to be operated...
  4. doi request reprint Early acid perception in NERD
    G Frieri
    Gastroenterology Unit, Internal Medicine Department, University of L Aquila, L Aquila, Italy
    Dis Esophagus 24:127-30. 2011
    ..It is hypothesized that the early onset of symptoms in NERD patients may be a possibility to avoid the progress of mucosal lesions by claiming an earlier medical care...
  5. ncbi request reprint Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment
    G Frieri
    Gastroenterology Unit, University of L Aquila, Italy
    Aliment Pharmacol Ther 13:1413-7. 1999
    ..To measure mucosal concentrations of mesalazine in ulcerative colitis patients treated with oral mesalazine alone, compared to patients treated with both topical and oral mesalazine...
  6. ncbi request reprint Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI
    V A Pupillo
    Dipartimento di Diagnostica per Immagini, Universita degli Studi di L Aquila, Via della Mainetta 88D, Coppito, L Aquila, Italy
    Radiol Med 112:798-809. 2007
    ..Our aim was to perform a dynamic study of contrast enhancement of the intestinal wall in patients with Crohn's disease to quantitatively assess local inflammatory activity...
  7. ncbi request reprint Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation
    R Sferra
    Department of Experimental Medicine, University of L Aquila, L Aquila, Italy
    Eur Rev Med Pharmacol Sci 16:1484-98. 2012
    ..Transforming growth factor-beta1 (TGF-beta)/Smad3 signalling plays a major role in tissue fibrogenesis acting as a potent stimulus of ECM accumulation...
  8. ncbi request reprint Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon
    Giovanni Latella
    Cattedra di Gastroenterologia, Universita di L Aquila, Via S Sisto 22E, 67100 L Aquila, Italy
    Int J Colorectal Dis 18:55-62. 2003
    ....
  9. ncbi request reprint GI distension in severe ulcerative colitis
    Giovanni Latella
    Gastroenterology Unit I, University La Sapienza, Rome, Italy
    Am J Gastroenterol 97:1169-75. 2002
    ..In this study we prospectively evaluated the prevalence of GI distension and its relationship to clinical outcome in patients with severe UC...